Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C].

Medicina clinica - 22 Jun 2015

Jiménez Macías Fernando Manuel, Barrero Alor Fátima, Casado Monge Pedro Germán, Ramos Lora Manuel, Pujol de la Llave Emilio, Ruíz-Frutos Carlos

Abstract excerpt

BACKGROUND AND OBJECTIVE: We analyzed baseline and kinetic characteristics of lipid metabolism during the first month of bitherapy in patients with chronic hepatitis C genotype 1 (CHC-1). PATIENTS AND METHODS: A longitudinal, prospective study including 99 naïve CHC-1 patients with liver biopsy who were treated with bitherapy. Our patients were assigned to one of 5 different "degrees of lipid requirement" that we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine CXCL10
Share to False Positive Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Liver

Share to Hypertriglyceridemia

Share to Lipoproteins

Share to Polyethylene Glycols

Share to ROC Curve

Share to Viremia

Source

Identifiers

PMID: 24726260
DOI: 10.1016/j.medcli.2013.12.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Lipid kinetics during dual antiviral therapy in patients with chronic hepatitis C].PMID 24726260Read ↗

Modulation of host lipid metabolism by hepatitis C virus: Role of new therapies.Semantic proximity Read ↗

Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance.Semantic proximity Read ↗

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment.Semantic proximity Read ↗

Brief Report: Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination.Semantic proximity Read ↗

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.Semantic proximity Read ↗

The cell biology of hepatitis C virus (HCV) lipid addiction: molecular mechanisms and its potential importance in the clinic.Semantic proximity Read ↗

INCREASE OF LIPIDS DURING HCV TREATMENT: VIRUS ACTION OR MEDICATION?Semantic proximity Read ↗

Reliance of Host Cholesterol Metabolic Pathways for the Life Cycle of Hepatitis C VirusSemantic proximity Read ↗

The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.Semantic proximity Read ↗

Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort.Semantic proximity Read ↗

Effect of antiviral therapy for HCV on lipid levels.Semantic proximity Read ↗

Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.